SCHEMBL13025908

SCHEMBL13025908

CCCc1ccc(-c2ccc(C(=O)Oc3ccc(C)c(C(F)F)c3F)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.39
THRB P10828 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RARB P10826 6/20 0.37
PLK1 P53350 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
RARA P10276 1/20 0.36
MTOR P42345 1/20 0.36
NR2F2 P24468 1/20 0.35
PAX8 Q06710 1/20 0.35
KLF5 Q13887 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ACACB O00763 1/20 0.35
ACACA Q13085 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12834352 0.96 THRB (0.40) MAPTTHRBSMN1; SMN2PLK1ALDH1A1
SCHEMBL13025742 0.85 MAPT (0.46) MAPTTHRBSMN1; SMN2RARBPLK1
SCHEMBL13025840 0.82 RARB (0.49) MAPTTHRBSMN1; SMN2RARBALDH1A1
SCHEMBL13025669 0.81 THRB (0.43) MAPTTHRBSMN1; SMN2PLK1ALDH1A1
SCHEMBL13025906 0.81 FFAR4 (0.38) ACACBACACA
SCHEMBL13025825 0.81 MPL (0.39) MAPTTHRBSMN1; SMN2RARBPLK1
SCHEMBL12737463 0.80 THRB (0.42) MAPTTHRBSMN1; SMN2RARBPLK1
SCHEMBL12742636 0.80 THRB (0.42) MAPTTHRBSMN1; SMN2RARBPLK1
SCHEMBL13025915 0.80 S1PR1 (0.33) RARBRARA
SCHEMBL10383005 0.79 MAPT (0.46) MAPTTHRBSMN1; SMN2RARBPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device CCND2, YBX1, CNKSR1 MAPT 1989/4885THRB 4115/4885SMN1; SMN2 3745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.